Despite the impact of the pandemic on cancer care, Perjeta grew 17% to CHF 2.9 billion ($3.2 billion) in the first nine months of 2020, now just fractionally behind Herceptin which declined 31% to ...

Mundipharma has signed a deal with Celltrion to market a biosimilar of Roche’s Herceptin (trastuzumab) in seven European countries. Breast cancer blockbuster Herceptin earned $2.26 billion in ...

The decision means about 300 patients each year will be treated with herceptin at a cost of about £7.9m per year. The Greater Manchester Medicines Management Group, the Greater Manchester Strategic ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. A randomized ...

A leading breast cancer specialist who spoke out about the injustice of 'postcode prescribing' in the National Health Service has been suspended from her post ...